Skip to main content
Premium Trial:

Request an Annual Quote

University of Rochester Reaps $4M Gift for Cancer Genomics

NEW YORK (GenomeWeb) – The University of Rochester has received a $4 million donation from the James P. Wilmot Foundation to fund the recruitment of a senior researcher in cancer genomics and to cover startup costs for the scientist's lab.

The investment is part of a $30 million research-focused campaign at UR Medicine to fund the new Wilmot Cancer Institute, which will consolidate all of the university's cancer research under one organization, UR said Saturday. The new grant will create the Wilmot Distinguished Professorship in Cancer Genomics.

UR launched the new cancer institute last week, and on Monday said it has opened the new UR Medicine Comprehensive Breast Care at Pluta facility, which will house the university's multidisciplinary breast cancer program.

UR decided to transition the pre-existing Wilmot Cancer Center into the new Wilmot Cancer Institute structure as a response to recent changes in the university's cancer program, including expansions of its facilities, the reorganization of its research teams into four areas, and increasing numbers of in-patient visits.

UR Medicine said the strategy it has developed for the Wilmot Cancer Institute will enable all of its oncologists and patients to access genomics and advanced diagnostic testing for certain cancers, clinical trials, weekly tumor board sessions, UR's electronic health records system, and other services.

"In a field that’s advancing as rapidly as cancer, it’s a tremendous advantage to have researchers and oncologists working together in the same facilities," UR President Joel Seligman said in a statement. "New research findings quickly make their way into clinical decision making."

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.